AB 837 amends two sections of California’s Health and Safety Code to include ketamine among the substances covered by major trafficking and possession-for-sale offenses. The measure makes transporting, importing, selling, furnishing, administering, giving away, offering to do those acts, or attempting to import or transport ketamine subject to felony penalties that can include multi-year prison terms.
The change does not reschedule ketamine; instead it treats certain conduct involving ketamine the same way the law already treats trafficking in other listed controlled substances. That creates new criminal exposure for supply-chain actors, clinicians and clinics that handle ketamine, and out‑of‑state shipments into California, while also shifting enforcement and local costs onto counties and prosecutors (the bill declares no state reimbursement).
At a Glance
What It Does
The bill inserts ketamine into the lists of controlled substances governed by Sections 11379.2 and 11352 of the Health and Safety Code, making transport, importation into California, sale, furnishing, administration, and offers or attempts to do those acts criminal. It defines "transports" as "to transport for sale" and ties penalties to existing sentencing brackets in Penal Code Section 1170.
Who It Affects
Medical and veterinary prescribers, ketamine clinics (including off‑label psychiatric use), pharmacies and wholesale distributors, couriers and shippers, and criminal justice actors (police, prosecutors, public defenders, and local jails). It also affects out‑of‑state suppliers that ship ketamine into California.
Why It Matters
By targeting conduct rather than rescheduling the drug, the bill extends felony trafficking exposure to a legally prescribed substance used in both medical and veterinary settings. That raises compliance and legal-risk questions for legitimate supply chains and care providers while giving prosecutors a clearer statutory basis to pursue diversion and illicit sales.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 837 amends two trafficking provisions in California’s Health and Safety Code so that ketamine is treated like the other controlled substances already subject to heavy criminal penalties for sale and transport. Rather than changing ketamine’s schedule classification, the bill simply lists ketamine among the substances covered by the statutes that make transportation, sale, furnishing, administration, and attempts or offers to do those acts felonies.
The short technical outcome: actions that move ketamine through the supply chain for illicit sale become explicit felony offenses under California law.
The bill preserves the statutory carve‑out for legally prescribed uses — it leaves in place the exception for written prescriptions from licensed physicians, dentists, podiatrists, or veterinarians — but makes clear that importing into the state, transporting for sale, offering to transport, and attempted importation are prosecutable acts when they fall outside those exceptions. The text also spells out that "transports" means transporting for sale, which focuses the statute on commercial diversion rather than mere movement of legally prescribed supplies.On penalties, AB 837 relies on existing sentencing ranges in Penal Code Section 1170: most covered trafficking carries terms of three, four, or five years; moving controlled substances between noncontiguous counties carries higher terms (three, six, or nine years).
For possession-for-sale offenses under the amended provision, the bill retains the existing county‑jail or state‑prison options. Finally, the bill includes the standard state constitutional clause declaring that no state reimbursement to local agencies is required, effectively leaving any added local enforcement, prosecution, and incarceration costs with counties.
The Five Things You Need to Know
The bill amends Health and Safety Code Sections 11379.2 and 11352 to place ketamine within the statutes that criminalize transporting, importing into California, selling, furnishing, administering, giving away, offering to do those acts, and attempting to import or transport controlled substances.
The statute explicitly defines "transports" as "to transport for sale," signaling the provision targets commercial diversion rather than mere movement of legally prescribed product.
Most trafficking covered by the amended statutes is punishable under Penal Code Section 1170’s three, four, or five‑year terms; transporting a covered substance from one county to a noncontiguous county carries enhanced terms of three, six, or nine years.
Possession for sale under the amended Section 11379.2 remains punishable by county jail for up to one year or by state prison, preserving a lower penalty tier for certain possession-for-sale offenses distinct from the trafficking terms.
The bill includes a no‑reimbursement statement under Article XIII B, Section 6 of the California Constitution, which leaves any additional local costs from prosecutions and incarceration to counties.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Possession‑for‑sale and related offenses — ketamine added
This amendment brings ketamine within the scope of the section that addresses possession for sale and related conduct for substances listed in subdivision (g) of Section 11056. Practically, that means a person caught possessing ketamine with intent to sell, or selling it, faces the existing penalties in that statute (county jail up to one year or state prison under specified sentencing rules). The section also covers furnishing, administering, and giving away, and retains the prescription exception for licensed practitioners; its principal effect is to make possession-for-sale of ketamine plainly prosecutable under this established provision.
Trafficking and transport offenses — ketamine included
This section is the heavier trafficking statute. By inserting ketamine into the list of controlled substances that trigger Section 11352’s penalties, the bill subjects a wide set of conduct — transporting for sale, importing into California, selling, furnishing, administering, giving away, offering to do those acts, and attempting import/transport — to felony exposure under Penal Code Section 1170 (three, four, or five years). The section also keeps a distinct enhancement where transporting across county lines to a noncontiguous county increases the sentencing bracket to three, six, or nine years. For compliance officers and shippers, the explicit expansion to include attempts and offers raises prosecutorial leverage at earlier points in a supply chain.
No state reimbursement for local costs
The bill repeats the standard constitutional declaration that no state reimbursement is required because the act creates or changes crimes or penalties. While a boilerplate clause, its practical import is that counties — law enforcement, prosecutors, defenders, and local jails — will absorb the operational costs associated with additional prosecutions, incarcerations, and court time resulting from the expanded offenses.
This bill is one of many.
Codify tracks hundreds of bills on Criminal Justice across all five countries.
Explore Criminal Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- State and local prosecutors — The explicit statutory inclusion of ketamine in trafficking provisions gives prosecutors clearer charging options and earlier leverage (offers/attempts) against diversion and illicit distribution.
- Law enforcement agencies — Investigations targeting diversion of ketamine (street sales, illicit clinics, out‑of‑state shipments) gain a specific trafficking statute to support arrests and asset seizure efforts.
- Communities concerned with diversion — Neighborhoods and public‑safety organizations focused on preventing recreational misuse may see reduced availability if prosecutions successfully disrupt illicit supply chains.
Who Bears the Cost
- Ketamine clinics and mental‑health providers — Clinics offering ketamine‑assisted therapy face increased legal risk and compliance burdens around procurement, storage, and transport, with potential chilling effects on services.
- Pharmacies, distributors and shippers — Entities that handle interstate or intrastate shipments into California must tighten chain‑of‑custody and contractual controls to avoid felony exposure for shipments deemed "for sale."
- Counties and local justice systems — Police, prosecutors, defense counsel, and jails will likely absorb additional caseloads and incarceration costs because the bill expands prosecutable conduct and penalties, with no state reimbursement.
- Licensed prescribers and veterinarians — Although the bill preserves a prescription exception, ambiguous factual circumstances (e.g., bulk shipments, cross‑county transfers) could expose practitioners to investigation or prosecution unless documentation and protocols are rigorous.
Key Issues
The Core Tension
The central dilemma is whether to prioritize criminal enforcement against diversion of ketamine — a drug with legitimate, clinic‑based therapeutic uses — knowing that doing so raises legal and operational risks for legitimate medical, veterinary, and research supply chains and may chill access to care for patients.
The bill solves the policy problem of illicit ketamine distribution by treating diversion the same way the law treats trafficking in other listed substances, but it does so without adjusting regulatory pathways that support legitimate medical and veterinary use. That creates implementation friction: prosecutors must distinguish lawful medical supply‑chain movements from transactions that are "for sale," and courts will need to parse intent at earlier transactional stages (offers and attempts).
Proof requirements for "for sale" intent and for distinguishing lawful distribution channels may produce contested factual showdowns in many cases.
Another operational tension concerns interstate logistics and licensing. The statute’s reach into "importing into this state" and attempts to import raises questions about coordination with federal law and about how couriers and distributors document lawful shipments.
Rural and multi‑county healthcare providers that move supplies between facilities may incur disproportionate legal risk because the bill raises penalties for transport to noncontiguous counties. Finally, the no‑reimbursement clause transfers fiscal consequences to local governments; this may lead to uneven enforcement depending on county resources, and could produce pressure to pursue easy prosecutions rather than invest in diversion‑reduction or public‑health alternatives.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.